Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis

Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis

Zakariya Al Naamani, Kevin Gormley, Helen Noble, Olinda Santin, Mohammed Al Maqbali

Abstract Objective Patients undergoing haemodialysis may experience troubling symptoms such as fatigue, anxiety, depression and sleep quality, which may affect their quality of life. The main objective of this study is to determine the prevalence of fatigue, anxiety, depression and sleep quality among patients receiving haemodialysis during the coronavirus disease 2019 (COVID-19) pandemic, and to explore the contributing predictors. Methods A cross-sectional and descriptive correlational design using Qualtrics software was performed. Data were collected using the Functional Assessment of Cancer Therapy-Fatigue (FACT-F), the Hospital Anxiety and Depression Scale (HADS) and the Pittsburgh Sleep Quality Index (PSQI). Logistic regression analyses were used to explore the predictors that were associated with fatigue, anxiety, depression and sleep quality. Results Of the 123 patients undergoing haemodialysis who participated, 53.7% (n = 66) reported fatigue, 43.9% (n = 54) reported anxiety, 33.3% (n = 41) reported depression and 56.9% (n = 70) reported poor sleep. Fatigue, anxiety and sleep quality (P 

2021

Anxiety, covid-19, Depression, sleep quality, fatigue, haemodialysis

10.1186/s12882-021-02349-3

Epidemiology and Health

Korean Society of Epidemiology

Diseases of the genitourinary system. Urology